SPIN Self-Management Feasibility Trial
NCT03914781 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2020-01-28
Summary
The Scleroderma Patient-centered Intervention Network (SPIN) is an organization established by researchers, health care providers, and people living with scleroderma (systemic sclerosis; SSc) from Canada, the United States, Mexico, Australia, France, Spain, and the United Kingdom. The objectives of SPIN are (1) to assemble a large cohort of SSc patients who complete outcome assessments regularly in order to learn more about important problems faced by people living with SSc and (2) to develop and test a series of internet-based interventions to help patients manage problems related to SSc, including a self-management program (SPIN-SELF Program).
In the SPIN-SELF feasibility trial, eligible SPIN Cohort participants will be randomized to be offered the SPIN-SELF Program (in addition to usual care) or to usual care only. The SPIN-SELF Program was designed by SPIN members based on key tenets of behaviour change that have been successfully incorporated in programs for more common diseases and on patient input. It utilizes social modelling through educational videos of SSc patients describing their challenges and what they have done to cope with SSc, as well as videos teaching key self-management techniques. After an introduction to self-management and instructions on how to navigate the program, a short quiz comprised of one-item questions will direct patients to modules that are most relevant to their symptoms and disease management challenges. The program's modules address (1) pain; (2) skin care, finger ulcers, and Raynaud's; (3) sleep problems; (4) fatigue; (5) gastrointestinal symptoms; (6) itch; (7) emotions and stress; (8) body image concerns due to disfigurement; and (9) effective communication with healthcare providers.
The aim of the SPIN-SELF feasibility study is to collect data to assess the feasibility of planned procedures for the full-scale trial; required resources; and scientific aspects of the study (e.g., withdrawal rate, outcomes measures). These data will be used to determine whether it is feasible to carry out the main trial or whether changes need to be made before conducting a full-scale RCT of the SPIN-SELF Program.
Conditions
- Scleroderma
- Systemic Sclerosis
Interventions
- BEHAVIORAL
-
SPIN-SELF Program
The SPIN-SELF program utilizes social modelling through educational videos of scleroderma patients who describe their own challenges and what they have done to cope with living with scleroderma, as well as videos of patients and health professionals who teach key self-management techniques. The program includes sections on general self-management skills, including goal-setting and self-monitoring), progress tracking, sharing goals and progress with friends and family, and patient stories of experiences with using self-management techniques to cope with SSc symptoms. The program's 9 modules focus on (1) coping with pain; (2) skin care, finger ulcers and Raynaud's; (3) sleep problems; (4) fatigue; (5) gastrointestinal symptoms; (6) itch; (7) managing emotions and stress; (8) coping with body image concerns due to disfigurement; and (9) effective communication with healthcare providers.
Sponsors & Collaborators
-
Lady Davis Institute
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-07-05
- Primary Completion
- 2019-11-25
- Completion
- 2019-11-25
Countries
- Canada
Study Locations
More Related Trials
-
Taking Charge of Systemic Sclerosis
NCT02494401 ·Status: COMPLETED ·Phase: NA
-
Evaluating Tools to Communicate Scleroderma Research Results to Patients - Trial #1
NCT06373263 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Feasibility and Preliminary Effects of the Resilience-based, Energy Management to Enhance Wellbeing in Systemic Sclerosis (RENEW) Intervention
NCT04588714 ·Status: COMPLETED ·Phase: NA
-
Making it Work Program for Systemic Sclerosis
NCT06338722 ·Status: COMPLETED ·Phase: NA
-
Effects of a Personalized Standardized Rehabilitation Program in Systemic Sclerosis
NCT00318188 ·Status: COMPLETED ·Phase: NA
-
6-minute Pegboard Ring Test in Patients with Scleroderma
NCT06588959 ·Status: NOT_YET_RECRUITING
-
RENEW Scleroderma: A Peer-Mentored, Web Intervention for Resilience-based, Energy Management to Enhance Wellbeing and Fatigue
NCT04908943 ·Status: COMPLETED ·Phase: NA
-
Self-management Telehealth Program for Scleroderma
NCT06990386 ·Status: COMPLETED ·Phase: NA
-
Effectiveness and Safety of SAR156597 in Treating Diffuse Systemic Sclerosis
NCT02921971 ·Status: COMPLETED ·Phase: PHASE2
-
Exercise in People With Systemic Sclerosis
NCT05234671 ·Status: COMPLETED ·Phase: NA
-
Study of the Efficacy of Nintedanib+Tocilizumab in Patients With Systemic Sclerosis and Interstitial Lung Disease
NCT06297096 ·Status: RECRUITING ·Phase: PHASE3
-
Evaluation of Aesthetic Impact in Patients With Systemic Sclerosis
NCT03271320 ·Status: COMPLETED
-
Stress, Scleroderma and Quality of Life
NCT05617066 ·Status: COMPLETED ·Phase: NA
-
Medico-economic and Quality of Life Impact of Sjogren-associated Small Fiber Neuropathy
NCT03509064 ·Status: RECRUITING
-
Improvement of Hand Dysfunction by Arthritis in Systemic Sclerosis
NCT01834157 ·Status: UNKNOWN
-
Online Fatigue Intervention Program for People With Scleroderma
NCT04401943 ·Status: COMPLETED ·Phase: NA
-
Prospective Cohort of Patients With Systemic Sclerosis at Brest University Hospital With Biobanking
NCT05532865 ·Status: RECRUITING
-
Clinical Study of Divozilimab in Patients With Systemic Scleroderma
NCT05726630 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
The Effects of Telerehabilitation Based Exercise Program in Patients With Systemic Sclerosis
NCT05078749 ·Status: UNKNOWN ·Phase: NA
-
Treatment and Prevention of Progression of Interstitial Lung Disease in Systemic Sclerosis
NCT01858259 ·Status: UNKNOWN
-
A Non-Interventional Pilot Study Assessing Whether Lysyl Oxidase-like 2 (LOXL2) is Present in Subjects With Scleroderma
NCT01881529 ·Status: COMPLETED
-
Efficacy of a Personalized Rehabilitation Program of Facial Involvement in Systemic Sclerosis
NCT05177380 ·Status: UNKNOWN ·Phase: NA
-
A Comparison Between Two Educational Methods in the Rehabilitation of the Microstomia in Systemic Sclerosis
NCT03766243 ·Status: COMPLETED ·Phase: NA
-
EFFECTS OF THE MICRO REINJECTION OF AUTOLOGOUS ADIPOSE TISSUE IN THE FACE OF PATIENTS WITH SYSTEMIC SCLEROSIS
NCT02206672 ·Status: UNKNOWN ·Phase: NA
-
Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension
NCT02682511 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2